12 Sarcoma Clinical Trials in Phoenix, AZ (2026)

Q: How do I join a clinical trial in Phoenix?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you.

Recruiting Sarcoma Studies in Phoenix

NCT05691478Recruiting

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

This phase II/III trial tests the safety, side effects, and best dose of the drug cabozantinib in combination with standard chemotherapy, and to compare the effect of adding cabozantinib to standard c...

Phoenix, AZPHASE21,122 participantsNational Cancer Institute (NCI)

View Study Details

NCT07227961Recruiting

PROMIS and Mobility Evaluation in Sarcoma Patients

The goal of this is to validate the Patient-Reported Outcomes Measurement Information System (PROMIS) in sarcoma patients undergoing surgery, and to evaluate a novel smartphone app for collecting mobi...

Phoenix, AZ800 participantsUniversity of Calgary

View Study Details

NCT06422806Recruiting

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

This phase III trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with dedifferentiated liposarcoma (DD...

Phoenix, AZPHASE3365 participantsNational Cancer Institute (NCI)

View Study Details

NCT03016819Recruiting

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study evaluates the safety and effi...

Phoenix, AZPHASE3325 participantsAdvenchen Laboratories, LLC

View Study Details

NCT04031677Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dediffer...

Phoenix, AZPHASE3250 participantsEuropean Organisation for Research and Treatment of Cancer - EORTC

View Study Details

NCT05304585Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) whi...

Phoenix, AZPHASE3205 participantsChildren's Oncology Group

View Study Details

NCT07188532Recruiting

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

This clinical trial evaluates the effect of radiotherapy doses based on tumor size and tumor-specific characteristics (biologically-adapted) in treating patients with Ewing sarcoma. Radiotherapy uses ...

Phoenix, AZNA141 participantsMayo Clinic

View Study Details

NCT05235165Recruiting

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has ...

Phoenix, AZPHASE362 participantsChildren's Oncology Group

View Study Details

NCT05634369Recruiting

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

The purpose of this study is to determine if the addition of infusions of a type of immune cell called a "natural killer", or NK cell to the sarcoma chemotherapy regimen GEM/DOX (gemcitabine and docet...

Phoenix, AZPHASE150 participantsNationwide Children's Hospital

View Study Details

NCT07048249Recruiting

Single Arm Romiplostim to Prevent CIT

The goal of this clinical trial is to to assess the efficacy of romiplostim as a supportive care measure in patients with a new diagnosis of Ewing sarcoma receiving interval-compressed chemotherapy. T...

Phoenix, AZEARLY_PHASE126 participantsChildren's Hospital Medical Center, Cincinnati

View Study Details

NCT05647265Recruiting

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

This phase II trial evaluates the safety and effectiveness of giving immunotherapy (nivolumab and ipilimumab) before surgery for controlling disease in patients with stage I-IIIa sarcomatoid mesotheli...

Phoenix, AZPHASE226 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT07194044Recruiting

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

This single arm study is designed to demonstrate the feasibility of a radically different approach for an exceptionally high-risk subset of MES with widely metastatic disease (WMES). We incorporate th...

Phoenix, AZPHASE115 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

About Sarcoma Clinical Trials in Phoenix

Sarcomas are rare cancers that arise in bone and soft tissues including muscle, fat, blood vessels, and connective tissue. There are more than 70 subtypes of sarcoma. Treatment usually involves surgery combined with radiation and/or chemotherapy.

There are currently 12 sarcoma clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 3,387 participants. Research is being sponsored by National Cancer Institute (NCI), University of Calgary, Advenchen Laboratories, LLC and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sarcoma Clinical Trials in Phoenix — FAQ

Are there sarcoma clinical trials in Phoenix?

Yes, there are 12 sarcoma clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Phoenix?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.

Are clinical trials in Phoenix free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.

What sarcoma treatments are being tested?

The 12 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma.

Data updated July 22, 2026 from ClinicalTrials.gov